392 related articles for article (PubMed ID: 22404947)
1. Epithelial-mesenchymal transition as a fundamental mechanism underlying the cancer phenotype.
Cervantes-Arias A; Pang LY; Argyle DJ
Vet Comp Oncol; 2013 Sep; 11(3):169-84. PubMed ID: 22404947
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.
Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G
Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760
[TBL] [Abstract][Full Text] [Related]
3. ZEB2 upregulates integrin α5 expression through cooperation with Sp1 to induce invasion during epithelial-mesenchymal transition of human cancer cells.
Nam EH; Lee Y; Park YK; Lee JW; Kim S
Carcinogenesis; 2012 Mar; 33(3):563-71. PubMed ID: 22227038
[TBL] [Abstract][Full Text] [Related]
4. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
Tsai JH; Hsu LS; Lin CL; Hong HM; Pan MH; Way TD; Chen WJ
Toxicol Appl Pharmacol; 2013 Nov; 272(3):746-56. PubMed ID: 23921149
[TBL] [Abstract][Full Text] [Related]
5. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion.
Cho SH; Park YS; Kim HJ; Kim CH; Lim SW; Huh JW; Lee JH; Kim HR
Int J Oncol; 2012 Jul; 41(1):211-8. PubMed ID: 22552741
[TBL] [Abstract][Full Text] [Related]
6. TGF-β signaling and epithelial-mesenchymal transition in cancer progression.
Katsuno Y; Lamouille S; Derynck R
Curr Opin Oncol; 2013 Jan; 25(1):76-84. PubMed ID: 23197193
[TBL] [Abstract][Full Text] [Related]
7. [Epithelial-mesenchymal transition in cancer progression].
Gos M; Miłoszewska J; Przybyszewska M
Postepy Biochem; 2009; 55(2):121-8. PubMed ID: 19824467
[TBL] [Abstract][Full Text] [Related]
8. Epithelial-to-mesenchymal transition: what is the impact on breast cancer stem cells and drug resistance.
Mallini P; Lennard T; Kirby J; Meeson A
Cancer Treat Rev; 2014 Apr; 40(3):341-8. PubMed ID: 24090504
[TBL] [Abstract][Full Text] [Related]
9. Colon cancer at the molecular level--usefulness of epithelial-mesenchymal transition analysis.
Todosi AM; Gavrilescu MM; Aniţei GM; Filip B; Scripcariu V
Rev Med Chir Soc Med Nat Iasi; 2012; 116(4):1106-11. PubMed ID: 23700897
[TBL] [Abstract][Full Text] [Related]
10. Epithelial-mesenchymal transition is regulated at post-transcriptional levels by transforming growth factor-β signaling during tumor progression.
Saitoh M
Cancer Sci; 2015 May; 106(5):481-8. PubMed ID: 25664423
[TBL] [Abstract][Full Text] [Related]
11. The epithelial to mesenchymal transition in pancreatic cancer: A systematic review.
Beuran M; Negoi I; Paun S; Ion AD; Bleotu C; Negoi RI; Hostiuc S
Pancreatology; 2015; 15(3):217-25. PubMed ID: 25794655
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of integrin-linked kinase correlates with malignant phenotype in non-small cell lung cancer and promotes lung cancer cell invasion and migration via regulating epithelial-mesenchymal transition (EMT)-related genes.
Chen D; Zhang Y; Zhang X; Li J; Han B; Liu S; Wang L; Ling Y; Mao S; Wang X
Acta Histochem; 2013 Mar; 115(2):128-36. PubMed ID: 22683084
[TBL] [Abstract][Full Text] [Related]
13. Emerging evidence of epithelial-to-mesenchymal transition in lung carcinogenesis.
Sato M; Shames DS; Hasegawa Y
Respirology; 2012 Oct; 17(7):1048-59. PubMed ID: 22452538
[TBL] [Abstract][Full Text] [Related]
14. EGCG inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition via the inhibition of Smad2 and Erk1/2 signaling pathways in nonsmall cell lung cancer cells.
Liu LC; Tsao TC; Hsu SR; Wang HC; Tsai TC; Kao JY; Way TD
J Agric Food Chem; 2012 Oct; 60(39):9863-73. PubMed ID: 22957988
[TBL] [Abstract][Full Text] [Related]
15. Epithelial-mesenchymal transition triggers cancer stem cell generation in human thyroid cancer cells.
Lan L; Luo Y; Cui D; Shi BY; Deng W; Huo LL; Chen HL; Zhang GY; Deng LL
Int J Oncol; 2013 Jul; 43(1):113-20. PubMed ID: 23604232
[TBL] [Abstract][Full Text] [Related]
16. Cadherins and epithelial-to-mesenchymal transition.
Gheldof A; Berx G
Prog Mol Biol Transl Sci; 2013; 116():317-36. PubMed ID: 23481201
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of epithelial and mesenchymal proteins in a panel of prostate cancer cell lines.
Murali AK; Norris JS
J Urol; 2012 Aug; 188(2):632-8. PubMed ID: 22704442
[TBL] [Abstract][Full Text] [Related]
18. Targeted therapy of epigenomic regulatory mechanisms controlling the epithelial to mesenchymal transition during tumor progression.
Mishra VK; Johnsen SA
Cell Tissue Res; 2014 Jun; 356(3):617-30. PubMed ID: 24833164
[TBL] [Abstract][Full Text] [Related]
19. Short hairpin RNA targeting FOXQ1 inhibits invasion and metastasis via the reversal of epithelial-mesenchymal transition in bladder cancer.
Zhu Z; Zhu Z; Pang Z; Xing Y; Wan F; Lan D; Wang H
Int J Oncol; 2013 Apr; 42(4):1271-8. PubMed ID: 23403865
[TBL] [Abstract][Full Text] [Related]
20. Interplay between microRNAs and WNT/β-catenin signalling pathway regulates epithelial-mesenchymal transition in cancer.
Ghahhari NM; Babashah S
Eur J Cancer; 2015 Aug; 51(12):1638-49. PubMed ID: 26025765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]